Which essential tremor phenotypes benefit most from wearable peripheral nerve stimulator devices?

a.k.a. transcutaneous afferent patterned stimulation (TAPS), e.g. Cala kIQ

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you convert between tetrabenazine, deutetrabenazine, or valbenazine for management of tardive dyskinesia?

In advanced Parkinson’s disease, how should clinicians assess symptom management and quality of life when patients are no longer able to communicate themselves?

What is your approach to escalating therapies for stiff person syndrome that is refractory to IVIG and steroids?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.